Medicamen Biotech Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter and nine months ended December 31, 2025.

The company's Registrar and Share Transfer Agent has furnished the details of securities dematerialized/rematerialized during the specified period to all the stock exchanges where Medicamen Biotech Limited is listed. The company confirms that the securities in the certificates have been listed on the stock exchanges and that the certificates have been duly verified, mutilated, and cancelled, with the depository's name substituted as the registered owner within 30 days of receipt.

This submission is a routine compliance filing.